Spleenex V
NDC 44911-0539, Aralia Quinquefolia, Potassium Gluconate, Ginkgo Biloba, Magnesium Gluconicum Dihydricum, Pancreas Suis, Spleen (Suis), Stomach (Suis), Germanium Sesquioxide, Cuprum Metallicum, Zincum Metallicum, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Magnesia Phosphorica, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Naphthochinonum, Aconiticum Acidum, Cis-, Natrum Oxalaceticum, liquid, from Energique, Inc..
- Product NDC
- 44911-0539
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0539 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMERICAN GINSENG3 [hp_X]/mL
- POTASSIUM GLUCONATE3 [hp_X]/mL
- GINKGO6 [hp_X]/mL
- MAGNESIUM GLUCONATE6 [hp_X]/mL
- SUS SCROFA PANCREAS6 [hp_X]/mL
- SUS SCROFA SPLEEN6 [hp_X]/mL
- SUS SCROFA STOMACH6 [hp_X]/mL
- GERMANIUM SESQUIOXIDE8 [hp_X]/mL
- COPPER8 [hp_X]/mL
- ZINC8 [hp_X]/mL
- OXOGLURIC ACID8 [hp_X]/mL
- ANHYDROUS CITRIC ACID8 [hp_X]/mL
- FUMARIC ACID8 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE8 [hp_X]/mL
- MALIC ACID8 [hp_X]/mL
- PYRUVIC ACID8 [hp_X]/mL
- SUCCINIC ACID8 [hp_X]/mL
- NAPHTHOQUINE9 [hp_X]/mL
- ACONITIC ACID, (Z)-12 [hp_X]/mL
- SODIUM DIETHYL OXALACETATE12 [hp_X]/mL
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Coagulation Factor Activity [PE]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0539-1 | 44911053901 | 30 mL in 1 BOTTLE, DROPPER (44911-0539-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0539 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0539 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0539. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.